Matthew Gribbin

Matthew Gribbin, DrPH, is a biostatistics executive currently serving as Senior Director of Statistical Innovation and Head of Biomedical Data Stewardship at Amgen. With extensive experience in oncology clinical trials, they have previously held leadership roles at organizations such as MedImmune, Human Genome Sciences, and Sanofi-Aventis Pharmaceuticals. Gribbin developed statistical methodologies as a Biostatistician at the Frank Porter Graham Child Development Institute and has taught statistics at North Carolina State University. They earned a Doctorate in Public Health from the University of North Carolina at Chapel Hill and an MBA from Arizona State University.